LanzaTech announces AMCI acquisition corp II shareholder meeting for approval of business combination scheduled for february 1, 2023
LanzaTech NZ, Inc. (“LanzaTech”), an innovative carbon capture and transformation (“CCT”) company that transforms waste carbon into materials such as sustainable fuels, fabrics, packaging, and other products that people use in their daily lives, announced that AMCI Acquisition Corp. II (“AMCI”) (Nasdaq: AMCI) has scheduled a special meeting of its stockholders (the “Special Meeting”) for February 1, 2023 at 11:00 a.m., Eastern Time, to approve the proposed business combination (the “Business Combination”) with LanzaTech.
AMCI also announced that it has filed its definitive proxy statement/prospectus for the Special Meeting, and has commenced mailing the definitive proxy statement/prospectus to its stockholders of record as of December 28, 2022, the record date for the Special Meeting (the “Record Date”).
The closing of the Business Combination is subject to approval by AMCI’s and LanzaTech’s stockholders and the satisfaction of other customary closing conditions and is expected to close as soon as practicable following the Special Meeting.
🔥 What about we co-host a webinar? Let's educate, captivate, and convert the biofuels economy!
Biofuels Central is the global go-to online magazine for the biofuel market, we can help you host impactful webinars that become a global reference on your topic and are an evergreen source of leads. Click here to request more details
Dr. Jennifer Holmgren, Chief Executive Officer of LanzaTech, said
We are thrilled to reach this important milestone in our journey towards becoming a public company via our partnership with AMCI.
“This transaction will enable a significant acceleration in the deployment of our CCT technology, bringing us as a society, one step closer to achieving a circular carbon economy and finding a solution for the challenges of decarbonizing modern heavy industry.”
If you are a stockholder entitled to vote at the Special Meeting, your vote is important no matter how many shares you own. You are encouraged to submit your vote as soon as possible. If you hold your shares in “street name,” meaning that your shares are held in an account at a brokerage firm, bank or other similar agent, you may vote prior to the Special Meeting by using your voting control number and instructions provided to you by your brokerage firm, bank or other similar agent.
Please contact your brokerage firm, bank or other similar agent to ensure your shares are voted. If you are a stockholder of record, you may vote prior to the Special Meeting by signing, dating, and mailing your proxy card in the return envelope provided with your proxy material.
If any AMCI stockholder has any questions, needs assistance in voting their shares or does not receive the Proxy Statement, that stockholder should contact their broker or Morrow Sodali, AMCI’s proxy solicitor, at (800) 662-5200, or by email to AMCI.info@investor.morrowsodali.com.
As announced on March 8th, 2022, LanzaTech has entered into a merger agreement with AMCI. Upon closing of the Business Combination, the combined company will be renamed LanzaTech Global, Inc. and its common stock is expected to be listed on Nasdaq under the ticker symbol “LNZA.”
READ the latest news shaping the biofuels market at Biofuels Central
LanzaTech Announces AMCI Acquisition Corp. II Shareholder Meeting For Approval Of Business Combination Scheduled For February 1, 2023, Chicago, January 12, 2023
